dual glp 1 glucagon receptor agonists Discovery of Biased Dual-Agonists of Glucagon-Like Peptide and Receptors through Mutation of a Conserved Aspartate From Diabetes to Oncology: Glucagon-like
Description
Superior average weight loss vs semaglutide

doi: 10.1021/jm9909645 [DOI] [PubMed] [Google Scholar] 132

Introduced around the 2000s, these drugs have opened new avenues in weight management strategies, heralding a paradigm shift in obesity treatment

Author Contributions H.A wrote main manuscript text, and created Tables 1 and 2

Miyamoto, S
